1-(4-Aminophenyl)-2,2,2-trifluoroethanone, 95.0%, 250mg

(S)-Methyl 2-amino-3-(5-methylpyridin-2-yl)propanoate hydrochloride, 95.0%, 1g

4-Fluorophenylacetic acid, 98.0%, 500g

3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione, 98.0%, 5mg

(3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one, 95.0%, 5g

BIS((1H-BENZO[D][1,2,3]TRIAZOL-1-YL)METHYL)AMINE, 95.0%, 1g

Potassium formate, 99.0%, 500g

4-(3-Chlorophenyl)cyclohexanone, 97%, 250mg

Methyl (5S,8S,11S)-11-(2-fluoroacetyl)-5-isopropyl-8-methyl-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatridecan-13-oate, 98%, 50mg

(9H-Fluoren-9-yl)methyl (S)-(1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)carbamate, 97%, 100mg

DL-alpha-Methoxyphenylacetic Acid>98.0%(GC)(T)5g

2-(5-(Trifluoromethyl)pyridin-2-yl)acetic acid, 95.0%, 1g

3-Fluorobenzenecarboximidamidehydrochloride, 95.0%, 1g